USPTO serial 79311087
NOVOTECH HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 15, 2022
- Examiner
- COLTON, BRITTANY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NOVOTECH HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew P. Hintz, Esq.
Matthew P. Hintz, Esq. Lowenstein Sandler LLPOne Lowenstein DriveRoseland, NJ 07068UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | conducting clinical trials for others; conducting and managing clinical trials for others in the field of pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others [scientific research]; providing medical and scientific research information about the results of clinical trials in the nature of clinical trials for pharmaceuticals and biotechnology; scientific research; medical research; preparation of statistics, namely, scientific analysis in the field of clinical trial results for scientific research; preparation of biostatistics, namely, scientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality evaluation of site compliance with clinical trial protocols and standards; preparation of reports and applications to regulators relating to aspects of clinical trials, namely, providing medical and scientific information and data in the field of conducting clinical trials; provision of medical and scientific research information and data between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards, namely, preparation of reports and applications on the quality and standard of clinical trials; technical writing of clinical report forms which are required by clinical trial drug protocols | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Novotech (Australia) Pty Ltd
- Other trademarks owned by Novotech (Australia) Pty Ltd
- Other trademarks owned by Novotech (Australia) Pty Ltd
- Other trademarks in Class 042
- Similar marks named NOVOTECH HEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 16, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 22, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 22, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 15, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 15, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 6, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 28, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 28, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 28, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 28, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 10, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 10, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 9, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 25, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 20, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |